5K is expected to draw more than 1,000 participants to the Scottsdale Sports Complex, helping fund TGen’s pancreatic cancer research
Arizona Diamondbacks President and CEO Derrick Hall for the first time is the honorary chair of the 2014 stepNout Run Walk Dash, funding pancreatic cancer research at the Translational Genomics Research Institute (TGen).
The 9th annual stepNout has a new location: the Scottsdale Sports Complex, northeast of Bell and Hayden roads. More participants are expected this year than ever before.
More than 1,000 people are expected to participate Nov. 2 in stepNout, which features fun, competitive races for all ages and abilities, including the event’s signature 5K run. Participants may register at the event. More information is available at www.tgenfoundation.org/step.
“Unfortunately, I lost my father to pancreatic cancer about three years ago,” Hall said. “It’s a terrible disease, and it’s usually not detected until it is in an advanced stage. By that point, there are few options. TGen is working on a method of early detection for pancreatic cancer, which this year will take the lives of nearly 40,000 Americans, the nation’s fourth-leading cause of cancer-related death.”
Erin Massey, Vice President of Development for Cancer Programs at the TGen Foundation, said: “Having an event chair like Derrick, who has been personally impacted by this disease, and who also understands TGen’s mission, provides an immediate connection to patients, their families and the thousands of concerned members of our community.”
TGen’s pancreatic cancer research is led by Dr. Daniel D. Von Hoff, TGen’s Distinguished Professor and Physician-In-Chief, and Chief Scientific Officer for the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with TGen. Dr. Von Hoff is one of the world’s leading authorities on pancreatic cancer.
“If anyone is going to make a difference in treating this disease, and perhaps one day finding a cure, it is Dr. Daniel Von Hoff,” said Hall, who also is a member of TGen’s National Advisory Council for Pancreatic Cancer Research.
Vowing to “fight pancreatic cancer, one step at a time,” stepNout aims to surpass the $1 million mark in fundraising. Participants have donated more than $750,000 since the event started in 2006 at Kiwanis Park in Tempe.
Mattress Firm, the nation’s leading bedding retailer, announced in August that it had agreed to be the presenting sponsor of stepNout.
If you go to stepNout
What: TGen’s 9th annual stepNout Run/Walk/Dash for pancreatic cancer research.
Where: Scottsdale Sports Complex, 8081 E. Princess Drive, northeast of Hayden and Bell roads, between Loop 101 and Frank Lloyd Wright Boulevard.
When: 7-11 a.m. Sunday, Nov. 2. Registration starts at 7 a.m.; races begin at 9 a.m.; an awards ceremony is set for 10 a.m.; and a kids’ dash is planned for 10:30 a.m.
Cost: Registration fees range from $15 to $35, depending on age and competition. Children ages 4 and under are free.
Registration: Register at the event.
More information: www.tgenfoundation.org/step.
About Mattress Firm
With more than 1,500 company-operated and franchised stores across 36 states, Mattress Firm (NASDAQ:MFRM) has the largest geographic footprint in the United States among multi-brand mattress retailers. Founded in 1986, Houston-based Mattress Firm is the nation’s leading bedding retailer with more than $1.2 billion in sales for 2013. The company offers a broad selection of both traditional and specialty mattresses, bedding accessories and other related products from leading manufacturers, including Sealy, Tempur-Pedic, Serta, Simmons, Stearns & Foster, Hampton & Rhodes and Atmos. Mattress Firm guarantees price, comfort and service with the ultimate goal of ensuring customers Save Money. Sleep Happy™. More information is available at mattressfirm.com.
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.